Philip M Grant Selected Research

Philip M Grant Research Topics

5	Infections 01/2022 - 07/2014
5	Opportunistic Infections (Opportunistic Infection) 07/2015 - 09/2010
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2015 - 09/2010
3	Chronic Hepatitis C 01/2022 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
3	HIV Infections (HIV Infection) 01/2020 - 08/2010
3	Immune Reconstitution Inflammatory Syndrome 12/2012 - 07/2010
2	Inflammation (Inflammations) 01/2021 - 07/2015
2	AIDS-Related Opportunistic Infections 09/2012 - 09/2010
1	Fibrosis (Cirrhosis) 01/2021
1	Sepsis (Septicemia) 01/2020
1	Disease Progression 01/2020
1	Critical Illness (Critically Ill) 01/2020
1	Cytokine Release Syndrome 01/2020
1	COVID-19 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Osteoporosis 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Bone Resorption 07/2015
1	Lymphopenia (Lymphocytopenia) 07/2015
1	Hepatitis C 11/2013
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2011
1	Cryptococcal Meningitis 10/2010
1	Mycoses (Diseases, Fungus) 07/2010
1	Injection Site Reaction 12/2009
1	Viremia 12/2009

5	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2010
3	CytokinesIBA 01/2021 - 12/2012
3	Interleukin-8 (Interleukin 8)IBA 01/2020 - 12/2012
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2015
1	velpatasvirIBA 01/2022
1	SofosbuvirIBA 01/2022
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Bispecific AntibodiesIBA 01/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	N 30IBA 07/2015
1	OsteocalcinIBA 07/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015
1	Atazanavir Sulfate (Reyataz)FDA Link 03/2015
1	Ritonavir (Norvir)FDA Link 03/2015
1	efavirenz (Sustiva)FDA Link 03/2015
1	Emtricitabine (Emtriva)FDA Link 03/2015
1	lamivudine drug combination abacavir FDA Link 03/2015
1	Hemoglobins (Hemoglobin)IBA 07/2014
1	Interleukin-17 (Interleukin 17)IBA 07/2014
1	AlbuminsIBA 07/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2013
1	Tenofovir (Viread)FDA Link 11/2013
1	GlucansIBA 07/2011
1	polyglucosanIBA 07/2011
1	Enfuvirtide (Fuzeon)FDA Link 12/2009
1	Raltegravir Potassium FDA Link 12/2009

7	Therapeutics 01/2020 - 09/2010
7	Art Therapy 01/2020 - 07/2010
1	Highly Active Antiretroviral Therapy (HAART) 09/2012
1	Ambulatory Care (Outpatient Care) 09/2010